170 related articles for article (PubMed ID: 37483744)
1. Glycyrrhizic acid glycosides reduces extensive tripterygium glycosides-induced lipid deposition in hepatocytes.
Yang Y; Fu X; Xia B; Zhou L; Zhang H; Li C; Ye X; Liu T
Heliyon; 2023 Jul; 9(7):e17891. PubMed ID: 37483744
[TBL] [Abstract][Full Text] [Related]
2. The protective effect and molecular mechanism of glycyrrhizic acid glycosides against Tripterygium glycosides induced nephrotoxicity based on the RhoA/ROCK1 signalling pathway.
Zhou L; Yang Y; Fu X; Xia B; Li C; Lu C; Qi Y; Zhang H; Liu T
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117100. PubMed ID: 37648177
[TBL] [Abstract][Full Text] [Related]
3. Qingluotongbi formula regulates the LXRα-ERS-SREBP-1c pathway in hepatocytes to alleviate the liver injury caused by Tripterygium wilfordii Hook. f.
Yu Z; Feng Z; Fu L; Wang J; Li C; Zhu H; Xie T; Zhou J; Zhou L; Zhou X
J Ethnopharmacol; 2022 Apr; 287():114952. PubMed ID: 34968661
[TBL] [Abstract][Full Text] [Related]
4. Protective Effect of Glycyrrhizic Acid on Alcoholic Liver Injury in Rats by Modulating Lipid Metabolism.
Huo X; Yang S; Sun X; Meng X; Zhao Y
Molecules; 2018 Jul; 23(7):. PubMed ID: 29973492
[TBL] [Abstract][Full Text] [Related]
5. CYP2E1 and miRNA-378a-3p contribute to acetaminophen- or tripterygium glycosides-induced hepatotoxicity.
Chen K; Guo N; Zhang R; Wei C; Guo R
Basic Clin Pharmacol Toxicol; 2020 Feb; 126(2):153-165. PubMed ID: 31468699
[TBL] [Abstract][Full Text] [Related]
6. Tripterygium glycoside fraction n2 ameliorates adriamycin-induced nephrotic syndrome in rats by suppressing apoptosis.
Wang XW; Tian RM; Yang YQ; Wang K; Li EN; Han XD; Bao K; Mao W; Xu HT; Liu B; Xu P
J Ethnopharmacol; 2020 Jul; 257():112789. PubMed ID: 32234597
[TBL] [Abstract][Full Text] [Related]
7. [Comparative study on dose-toxicity-effect of Tripterygium Glycosides Tablets and Tripterygium wilfordii Tablets on CIA model rats].
Liu LL; Tian YG; Su XH; Fan YF; Li C; Zhu XX; Cao W; Liu T; Wang HL; Xu Y; Kong XY; Lin N
Zhongguo Zhong Yao Za Zhi; 2019 Aug; 44(16):3502-3511. PubMed ID: 31602915
[TBL] [Abstract][Full Text] [Related]
8. [Toxicity-reducing effect of compatibility of Tripterygium and licorice in animals: systematic review].
Li HZ; Liu B; Shu HY; Yuan RL; Ji XY; Hu H; Meng X; Liu YQ; Shi NN; Wang YP; Lyu C
Zhongguo Zhong Yao Za Zhi; 2019 Aug; 44(16):3512-3519. PubMed ID: 31602916
[TBL] [Abstract][Full Text] [Related]
9. Tripterygium glycosides improve abnormal lipid deposition in nephrotic syndrome rat models.
Zheng B; Lu D; Chen X; Yin Y; Chen W; Wang X; Lin H; Xu P; Wu A; Liu B
Ren Fail; 2023 Dec; 45(1):2182617. PubMed ID: 36876728
[TBL] [Abstract][Full Text] [Related]
10. Segment-specific proximal tubule injury in tripterygium glycosides intoxicated rats.
Dan H; Peng RX; Ao Y; Liu YH
J Biochem Mol Toxicol; 2008; 22(6):422-8. PubMed ID: 19111004
[TBL] [Abstract][Full Text] [Related]
11. Low-dose of multi-glycoside of Tripterygium wilfordii Hook. f., a natural regulator of TGF-β1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo.
Wan YG; Che XY; Sun W; Huang YR; Meng XJ; Chen HL; Shi XM; Tu Y; Wu W; Liu YL
J Ethnopharmacol; 2014 Feb; 151(3):1079-1089. PubMed ID: 24362077
[TBL] [Abstract][Full Text] [Related]
12. Quercetin ameliorates liver injury induced with Tripterygium glycosides by reducing oxidative stress and inflammation.
Wang J; Miao M; Zhang Y; Liu R; Li X; Cui Y; Qu L
Can J Physiol Pharmacol; 2015 Jun; 93(6):427-33. PubMed ID: 25894526
[TBL] [Abstract][Full Text] [Related]
13. Valsartan in Combination with Tripterygium Glycosides Protects against Chronic Nephritis via the Toll-Like Receptor 4 Pathway.
Dong J; Huang D; Jing L; Wu M
Anal Cell Pathol (Amst); 2022; 2022():4807028. PubMed ID: 36061150
[TBL] [Abstract][Full Text] [Related]
14. Metabonomic and transcriptomic analyses of
An Z; Sun Y; Shi C; Liu L
Drug Chem Toxicol; 2023 Nov; 46(4):650-664. PubMed ID: 35603506
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Tripterygium Glycosides Tablets on reproductive toxicity in female rats with Ⅱ type collagen induced arthritis].
Fan YF; Xu Y; Su XH; Liu LL; Tian YG; Zhao Y; Kong XY; Lin N
Zhongguo Zhong Yao Za Zhi; 2019 Aug; 44(16):3486-3493. PubMed ID: 31602913
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics reveals the role of PPARα in Tripterygium Wilfordii-induced liver injury.
Dai M; Peng W; Zhang T; Zhao Q; Ma X; Cheng Y; Wang C; Li F
J Ethnopharmacol; 2022 May; 289():115090. PubMed ID: 35143937
[TBL] [Abstract][Full Text] [Related]
17. Tripterygium glycoside fraction n2: Alleviation of DSS-induced colitis by modulating immune homeostasis in mice.
Yang YQ; Wu YF; Xu FF; Deng JB; Wu LL; Han XD; Liang J; Guo DA; Liu B
Phytomedicine; 2019 May; 58():152855. PubMed ID: 30851581
[TBL] [Abstract][Full Text] [Related]
18. Different Doses of Tripterygium Glycosides in the Treatment of Diabetic Nephropathy: Effects on Blood Lipids.
Wang W
Kidney Blood Press Res; 2018; 43(3):931-937. PubMed ID: 29895032
[TBL] [Abstract][Full Text] [Related]
19. Toxicogenomic analysis of the gene expression changes in rat liver after a 28-day oral Tripterygium wilfordii multiglycoside exposure.
Zhang Y; Jiang Z; Xue M; Zhang S; Wang Y; Zhang L
J Ethnopharmacol; 2012 May; 141(1):170-7. PubMed ID: 22366672
[TBL] [Abstract][Full Text] [Related]
20. Synchronous Investigation of the Mechanism and Substance Basis of Tripterygium Glycosides Tablets on Anti-rheumatoid Arthritis and Hepatotoxicity.
Qian Q; Gao Y; Xun G; Wang X; Ge J; Zhang H; Mou F; Su S; Wang Q
Appl Biochem Biotechnol; 2022 Nov; 194(11):5333-5352. PubMed ID: 35763252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
